Work

A phase I study of the combination of a DNA topoisomerase inhibitor, idarubicin, with the histone deacetylase inhibitor vorinostat, in advanced acute leukemia

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.7066

Authors: T. M. Kadia, G. Borthakur, W. Wierda, F. Ravandi, S. Faderl, W. Newsome, J. Zwiebel, M. Egorin, G. Garcia-Manero

Institutions: National Institutes of Health, The University of Texas MD Anderson Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979363336

Cites:

Cited by: 3

Related to: 10